Terms: = Pancreatic cancer AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3 AND Prognosis
4321 results:
1. Effect of chemotherapy on prognosis in patients with primary pancreatic signet ring cell carcinoma: A large real-world study based on machine learning.
Huang K; Yuan X; Zhao P; He Y
PLoS One; 2024; 19(5):e0302685. PubMed ID: 38739633
[TBL] [Abstract] [Full Text] [Related]
2. GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction.
Zeng J; Li X; Zhang Y; Zhang B; Wang H; Bao S; Zu L; Zhang H; Cheng Y; Tang Q; Xu X; Xu S; Song Z
Aging (Albany NY); 2024 May; 16(9):7647-7667. PubMed ID: 38728250
[TBL] [Abstract] [Full Text] [Related]
3. Adjuvant chemotherapy omission after pancreatic cancer resection: a French nationwide study.
Poiraud C; Lenne X; Bruandet A; Theis D; Bertrand N; Turpin A; Truant S; El Amrani M
World J Surg Oncol; 2024 May; 22(1):123. PubMed ID: 38711136
[TBL] [Abstract] [Full Text] [Related]
4. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of chemoresistance characteristics and prognostic relevance of postoperative gemcitabine adjuvant chemotherapy in pancreatic cancer.
Ren J; Wu S; Su T; Ding J; Chen F; Li J; Wang Z; Han L; Wu Z
Cancer Med; 2024 May; 13(9):e7229. PubMed ID: 38698688
[TBL] [Abstract] [Full Text] [Related]
6. Targeting KRAS in pancreatic cancer.
Stickler S; Rath B; Hamilton G
Oncol Res; 2024; 32(5):799-805. PubMed ID: 38686056
[TBL] [Abstract] [Full Text] [Related]
7. Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study.
Zhang X; Zhu X; Zhong J; Zhao Y; Zhang X; Zhang W; Ye F; Yang C; Xue J; Xiong R; Wang J; Shen S; Pan Y; Li D; Song T; Bi X; Sun H; Xiang B; Gu S; Wen T; Lu S; Chen Y; Yin T; Liu L; Kuang M; Xu L; Li D; Cai J
Sci Rep; 2024 Apr; 14(1):9745. PubMed ID: 38679630
[TBL] [Abstract] [Full Text] [Related]
8. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
[TBL] [Abstract] [Full Text] [Related]
9. Minocycline and photodynamic priming significantly improve chemotherapy efficacy in heterotypic spheroids of pancreatic ductal adenocarcinoma.
Bano S; Alburquerque JQ; Roberts HJ; Pang S; Huang HC; Hasan T
J Photochem Photobiol B; 2024 Jun; 255():112910. PubMed ID: 38663337
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs.
Wei M; Lu L; Luo Z; Ma J; Wang J
BMC Gastroenterol; 2024 Apr; 24(1):142. PubMed ID: 38654165
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort study.
Kuwabara S; Takeuchi Y; Sato O; Mizota T; Ichinokawa M; Murakawa K; Aoki Y; Ishido K; Ono K; Hirano S
BMC Surg; 2024 Apr; 24(1):116. PubMed ID: 38643112
[TBL] [Abstract] [Full Text] [Related]
12. Fatty Acid Binding Protein 1 is an Independent Prognostic Biomarker for Gallbladder cancer with Direct Hepatic Invasion.
Qiu S; Liu Z; Hu J; Wang Z; Yue Z; Jia Z; Zhang W; Xue Z; Liu Z; Liu Y
Int J Med Sci; 2024; 21(5):862-873. PubMed ID: 38617005
[No Abstract] [Full Text] [Related]
13. A 15-Inflammation-Related Gene Signature Predicts the prognosis of Patients With pancreatic Ductal Adenocarcinoma.
Sun X; Song H; Sun X; Liao C; Wang G; Xu Y; Li L; Han Y; Xu C; Wang W; Cai S; Liang H; Yu H
Cancer Invest; 2024 Mar; 42(3):226-242. PubMed ID: 38616304
[TBL] [Abstract] [Full Text] [Related]
14. The preliminary analysis of lymphatic flow around the connective tissues surrounding SMA and SpA elucidates patients' oncological condition in borderline-resectable pancreatic cancer.
Akita H; Asukai K; Mukai Y; Hasegawa S; Omori T; Miyata H; Ohue M; Sakon M; Wada H; Takahashi H
BMC Surg; 2024 Apr; 24(1):107. PubMed ID: 38614983
[TBL] [Abstract] [Full Text] [Related]
15. Glycolysis and tumor progression promoted by the m
Yang K; Zhong Z; Zou J; Liao JY; Chen S; Zhou S; Zhao Y; Li J; Yin D; Huang K; Li Y
Cancer Lett; 2024 May; 590():216840. PubMed ID: 38604311
[TBL] [Abstract] [Full Text] [Related]
16. IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via STAT3/CD155 signaling axis.
Chen J; Sun S; Li H; Cai X; Wan C
Front Immunol; 2024; 15():1373321. PubMed ID: 38596684
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis.
Zhou Y; Liu Z; Cheng Y; Li J; Fu W
J Gastrointest Surg; 2024 Apr; 28(4):559-565. PubMed ID: 38583910
[TBL] [Abstract] [Full Text] [Related]
18. Predicting postoperative prognosis of pancreatic cancer using a computed tomography-based radio-clinical model: exploring biologic functions.
Yu C; Ruan Y; Yu L; Wang X; Hu Z; Zhu G; Huang T
J Gastrointest Surg; 2024 Apr; 28(4):458-466. PubMed ID: 38583896
[TBL] [Abstract] [Full Text] [Related]
19. Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrence.
Boros C; Sutter O; Cauchy F; Ganne-CarriƩ N; Nahon P; N'kontchou G; Ziol M; Grando V; Demory A; Blaise L; Dondero F; Durand F; Soubrane O; Lesurtel M; Laurent A; Seror O; Nault JC
Liver Int; 2024 Jun; 44(6):1464-1473. PubMed ID: 38581233
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic significance of systemic immune-inflammation index in patients with nonfunction pancreatic neuroendocrine tumor undergoing surgical resection.
Chen G; Liu L; Tan C; Tan Q; Chen Y; An X; Liu X; Wang X
Cancer Med; 2024 Apr; 13(7):e7114. PubMed ID: 38553949
[TBL] [Abstract] [Full Text] [Related]
[Next]